Organogenesis to expand product line | Acelity's advanced foam dressing line debuts in US | Irrigation, debridement, antibiotic beads might prevent amputation in DFI
April 20, 2016
Advanced Tissue SmartBrief
Your resource for current wound care information
Wound Care Update
Organogenesis to expand product line
Organogenesis will use $30 million raised recently from investors to expand commercial operations and products, including antimicrobial shields, burn treatments and soft tissue reinforcement products, the company announced.
The Boston Globe (tiered subscription model) (4/14) 
LinkedIn Twitter Facebook Google+ Email
Acelity's advanced foam dressing line debuts in US
Acelity has launched its TIELLE Foam Dressing products in the US as it seeks to expand its global role in wound care and regenerative medicine. The advanced foam dressings can be used for pressure ulcers, lower-extremity ulcers, minor burns and donor sites, as well as for traumatic and post-surgical wounds.
American City Business Journals/San Antonio (4/18) 
LinkedIn Twitter Facebook Google+ Email
Research, Technology & Innovation
Irrigation, debridement, antibiotic beads might prevent amputation in DFI
Serial irrigation and debridement with polymethylmethacrylate bead placement controlled diabetic foot infections in a small study and might be a useful protocol for limb salvage, writes podiatrist Monica Schweinberger. She describes the procedure for irrigation, debridement and bead placement, and the results of the retrospective study.
Podiatry Today magazine (4/2016) 
LinkedIn Twitter Facebook Google+ Email
Higher amputation, mortality rates seen in diabetic foot syndrome, study finds
Diabetic foot syndrome patients had the highest amputation rate and length of hospital stay and costs, as well as the lowest cumulative four-year survival and amputation-free survival, in a study of patients with DFS, diabetes and peripheral artery disease, or PAD alone. The findings, in the Journal of Diabetes and Its Complications, are based on data from 40,335 patients hospitalized between 2009 and 2011, and showed that diabetic foot syndrome patients had the lowest revascularization rate.
Healio (free registration)/Endocrine Today (4/15) 
LinkedIn Twitter Facebook Google+ Email
Health Policy & Regulation
CMS restores payment cuts under two-midnight rule
The CMS is rescinding cuts in payments to hospitals under the two-midnight rule and will temporarily increase payments by 0.6% in fiscal 2017 to compensate for the rate cuts.
Modern Healthcare (tiered subscription model) (4/18) 
LinkedIn Twitter Facebook Google+ Email
Calif. podiatrist gets 3 years for health care fraud
Neil Van Dyck, a podiatrist in Roseville, Calif., was sentenced to three years of federal imprisonment and ordered to pay a fine of $10,000 for health care fraud. Van Dyck pleaded guilty last year to fraudulently billing Medicare, Medi-Cal, Tricare and private insurance companies for more than $2.8 million worth of unprovided or unnecessary services, court documents say. Authorities said Van Dyck also cut single-use skin patches into pieces and billed for multiple applications.
The Sacramento Bee (Calif.) (tiered subscription model) (4/15) 
LinkedIn Twitter Facebook Google+ Email
Learn more about ADVTIS:
Meet Our People | Placing an Order
Why Use Advanced Tissue | Home
Take action. Success is not guaranteed, but inaction will guarantee failure.
Ken Poirot,
LinkedIn Twitter Facebook Google+ Email
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.
Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information